U.S. pharma huge copyright scrapped two experimental weight loss tablets final yr—a once-every day capsule, lotiglipron, resulting from elevated liver enzymes plus a twice-every day pill, danuglipron, resulting from solid Unintended effects—but CEO Albert Bourla has stated the company is set to “Perform and gain” from the weight problems Pl